Log in

002880 Shenzhen Weiguang Biological Products Co., Ltd. SZSE · China

Shenzhen Weiguang Biological Products Co. (002880) news

Shenzhen Weiguang Biological Products Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002880, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Shenzhen Weiguang Biological Products Co. news

We have not published a story on Shenzhen Weiguang Biological Products Co. yet. When there is news, it will appear here.

Questions about Shenzhen Weiguang Biological Products Co.

What is the ticker symbol of Shenzhen Weiguang Biological Products Co.?

Shenzhen Weiguang Biological Products Co., Ltd. trades under the ticker 002880 on SZSE.

Where is Shenzhen Weiguang Biological Products Co. listed?

Shenzhen Weiguang Biological Products Co., Ltd. is listed on SZSE.

Which country or territory is Shenzhen Weiguang Biological Products Co. listed under?

Our directory records Shenzhen Weiguang Biological Products Co., Ltd. under China.

What does Shenzhen Weiguang Biological Products Co. do?

Our directory classifies Shenzhen Weiguang Biological Products Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Shenzhen Weiguang Biological Products Co.?

The ISIN recorded for Shenzhen Weiguang Biological Products Co., Ltd. is CNE100002Q58.

Does aibio.space cover Shenzhen Weiguang Biological Products Co.?

aibio.space lists Shenzhen Weiguang Biological Products Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Shenzhen Weiguang Biological Products Co.?

Companies in our directory listed in the same country and business area as Shenzhen Weiguang Biological Products Co.: XtalPi Holdings, Beijing Bohui Innovation Biotechnology Group Co., Shenzhen Kangtai Biological Products Co., Shanghai RAAS Blood Products Co., Innovita Biological Technology Co., TenNor Therapeutics Suzhou.

Investor discussion: Shenzhen Weiguang Biological Products Co.

Members talk about Shenzhen Weiguang Biological Products Co. (002880). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:002880 on TradingView.

Listing details

Shenzhen Weiguang Biological Products Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002880, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Shenzhen Weiguang Biological Products Co., Ltd.
Ticker
002880
Listing
SZSE
Country or territory
China
Business scope
Biotechnology
ISIN
CNE100002Q58
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.